Skip to content

CRBP - Corbus Pharmaceuticals Holdings, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Corbus Pharmaceuticals Holding

CRBP · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CRBPCorbus Pharmaceuticals Holding

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $20.56
52-wk low: $7.12
Prev close: $15.49
Mkt cap: $193.2M
Beta: 2.62
P/S: 169.9x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$18.9M

JS
Jim Simons
Q2 2026 13F
$1.0M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 39.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $193M

Valuation

P/S169.88
P/B1.91

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CRBP
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $193.22M
Beta: 2.62

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.9x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-95.6%

$864K

position

MW

Marshall Wace

Q2 2026 13F

$744K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CRBP

No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.81-39.2%

-$1.30 expected

Next report

What the street expects next

EPS expected

-$1.21

-$1.91 to -$0.73

Revenue expected

$1.1M

9 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

0.18

Change in 30 days

-95.6%

ROA-53.0%

Growth

Beta2.62